2926 - 2950 of 6557 Results
Title
Year
-
OPENTitle: Neuronal hyperactivity–induced oxidant stress promotes in vivo α-synuclein brain spreadingJournal Name: Science AdvancesPublisher: American Association for the Advancement of Science (AAAS)Vol: 8Issue #: 35Start Page: eabn0356End Page: eabn0356Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1126/sciadv.abn0356Best OA location URL: https://www.science.org/doi/pdf/10.1126/sciadv.abn0356?download=trueCitation Count: 37
-
OPENTitle: Screening for impulse control symptoms in patients with de novo Parkinson diseaseJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 80Issue #: 2Start Page: 176End Page: 180Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31827b915cBest OA location URL: https://n.neurology.org/content/neurology/80/2/176.full.pdfCitation Count: 189
-
OPENTitle: Effects of Baseline CSF α-Synuclein on Regional Brain Atrophy Rates in Healthy Elders, Mild Cognitive Impairment and Alzheimer’s DiseaseJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 12Start Page: e85443End Page: e85443Publication Date:Open Access(OA) Status: OPENLicense: cc0DOI - Digital Object Identifier: 10.1371/journal.pone.0085443Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0085443&type=printableCitation Count: 18
-
OPENTitle: Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline SummaryJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 20Start Page: 942End Page: 957Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012868Best OA location URL: https://n.neurology.org/content/neurology/97/20/942.full.pdfCitation Count: 189
-
OPENTitle: Testing the Protein Propagation Hypothesis of Parkinson DiseaseJournal Name: Journal of Experimental NeurosciencePublisher: SAGE PublicationsVol: 12Issue #:Start Page: 1179069518786715End Page: 1179069518786715Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1179069518786715Best OA location URL: https://journals.sagepub.com/doi/pdf/10.1177/1179069518786715Citation Count: 33
-
OPENTitle: Clinical Comparison of 99mTc Exametazime and 123I Ioflupane SPECT in Patients with Chronic Mild Traumatic Brain InjuryJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 9Issue #: 1Start Page: e87009End Page: e87009Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0087009Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0087009&type=printableCitation Count: 16
-
OPENTitle: Longitudinal dysregulation of long non-coding RNAs in Parkinson’s diseaseJournal Name: Experimental Biology and MedicinePublisher: Frontiers Media SAVol: 248Issue #: 20Start Page: 1780End Page: 1784Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15353702231198078Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10792423/pdf/10.1177_15353702231198078.pdfCitation Count: 3
-
OPENTitle: Synapsin III is a key component of α‐synuclein fibrils in Lewy bodies of PD brainsJournal Name: Brain PathologyPublisher: WileyVol: 28Issue #: 6Start Page: 875End Page: 888Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bpa.12587Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8028549Citation Count: 51
-
OPENTitle: Digital health technology for Parkinson's disease with comprehensive monitoring and artificial intelligence-enabled haptic biofeedback for bulbar dysfunctionJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 3Start Page: 630End Page: 645Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x251329354Best OA location URL: https://doi.org/10.1177/1877718x251329354Citation Count: 9
-
OPENTitle: Identification and in vitro characterization of C05-01, a PBB3 derivative with improved affinity for alpha-synucleinJournal Name: Brain ResearchPublisher: Elsevier BVVol: 1749Issue #:Start Page: 147131End Page: 147131Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.brainres.2020.147131Best OA location URL: https://doi.org/10.1016/j.brainres.2020.147131Citation Count: 32
-
OPENTitle: Characterization of a Cul9–Parkin double knockout mouse model for Parkinson’s diseaseJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page: 16886End Page: 16886Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-020-73854-yBest OA location URL: https://www.nature.com/articles/s41598-020-73854-y.pdfCitation Count: 9
-
OPENTitle: Disease-Specific Regions Outperform Whole-Brain Approaches in Identifying Progressive Supranuclear Palsy: A Multicentric MRI StudyJournal Name: Frontiers in NeurosciencePublisher: Frontiers Media SAVol: 11Issue #:Start Page: 100End Page: 100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnins.2017.00100Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnins.2017.00100/pdfCitation Count: 22
-
OPENTitle: T2-Imaging Changes in the Nigrosome-1 Relate to Clinical Measures of Parkinson’s DiseaseJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 7Issue #:Start Page: 174End Page: 174Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2016.00174Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2016.00174/pdfCitation Count: 11
- Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK22018OPENTitle: Insights into the Influence of Specific Splicing Events on the Structural Organization of LRRK2Journal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 19Issue #: 9Start Page: 2784End Page: 2784Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms19092784Best OA location URL: https://www.mdpi.com/1422-0067/19/9/2784/pdf?version=1537093660Citation Count: 2
-
OPENTitle: Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse ModelJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 10Issue #:Start Page: 981End Page: 981Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2019.00981Best OA location URL: https://www.frontiersin.org/articles/10.3389/fimmu.2019.00981/pdfCitation Count: 60
-
OPENTitle: Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophagesJournal Name: Journal for ImmunoTherapy of CancerPublisher: BMJVol: 8Issue #: 2Start Page: e001617End Page: e001617Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.1136/jitc-2020-001617Best OA location URL: https://jitc.bmj.com/content/jitc/8/2/e001617.full.pdfCitation Count: 49
-
OPENTitle: Amygdalar and hippocampal volume loss in limbic-predominant age-related TDP-43 encephalopathyJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 148Issue #: 11Start Page: 3913End Page: 3923Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/brain/awaf201Best OA location URL: https://academic.oup.com/brain/advance-article-pdf/doi/10.1093/brain/awaf201/63485731/awaf201.pdfCitation Count: 15
-
OPENTitle: L-DOPA functionalized, multi-branched gold nanoparticles as brain-targeted nano-vehiclesJournal Name: Nanomedicine: Nanotechnology, Biology and MedicinePublisher: Elsevier BVVol: 15Issue #: 1Start Page: 1End Page: 11Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nano.2018.08.011Best OA location URL: http://hdl.handle.net/10044/1/63483Citation Count: 100
-
OPENTitle: Elevated In Vitro Kinase Activity in Peripheral Blood Mononuclear Cells of Leucine‐Rich Repeat Kinase 2 G2019S Carriers: A Novel Enzyme‐Linked Immunosorbent Assay–Based MethodJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 11Start Page: 2095End Page: 2100Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28175Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28175Citation Count: 33
- Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonism2020OPENTitle: Co-occurring WARS2 and CHRNA6 mutations in a child with a severe form of infantile parkinsonismJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 72Issue #:Start Page: 75End Page: 79Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.02.003Best OA location URL: http://hdl.handle.net/11577/3350481Citation Count: 21
-
OPENTitle: Video-based Parkinson’s disease assessments in a nationwide cohort of Fox Insight participantsJournal Name: Clinical Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 4Issue #:Start Page: 100094End Page: 100094Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.prdoa.2021.100094Best OA location URL: https://doi.org/10.1016/j.prdoa.2021.100094Citation Count: 35
-
OPENTitle: Levodopa Versus Dopamine Agonist after Subthalamic Stimulation in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 3Start Page: 672End Page: 680Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28382Best OA location URL: https://doi.org/10.1002/mds.28382Citation Count: 23
-
OPENTitle: The Interaction between HLA‐DRB1 and Smoking in Parkinson's Disease RevisitedJournal Name: Movement DisordersPublisher: WileyVol: 37Issue #: 9Start Page: 1929End Page: 1937Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/mds.29133Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29133Citation Count: 14
-
OPENTitle: Complementary Mitochondrial and α‐Synuclein Signatures Refine Biological Stratification of Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 41Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.70437Best OA location URL: https://doi.org/10.1002/mds.70437Citation Count: 0
-
OPENTitle: A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein MiceJournal Name: Annals of NeurologyPublisher: WileyVol: 89Issue #: 1Start Page: 74End Page: 90Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1002/ana.25920Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/ana.25920Citation Count: 67